BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 12902486)

  • 1. Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice.
    Whyburn LR; Halcomb KE; Contreras CM; Lowell CA; Witte ON; Satterthwaite AB
    J Immunol; 2003 Aug; 171(4):1850-8. PubMed ID: 12902486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways.
    Satterthwaite AB; Lowell CA; Khan WN; Sideras P; Alt FW; Witte ON
    J Exp Med; 1998 Sep; 188(5):833-44. PubMed ID: 9730885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular maturation defects in Bruton's tyrosine kinase-deficient immature B cells are amplified by premature B cell receptor expression and reduced by receptor editing.
    Middendorp S; Hendriks RW
    J Immunol; 2004 Feb; 172(3):1371-9. PubMed ID: 14734712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of autoimmune disease in Lyn-deficient mice by the mutation of the Btk gene.
    Takeshita H; Taniuchi I; Kato J; Watanabe T
    Int Immunol; 1998 Apr; 10(4):435-44. PubMed ID: 9620599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bruton's Tyrosine Kinase Synergizes with Notch2 To Govern Marginal Zone B Cells in Nonobese Diabetic Mice.
    Case JB; Bonami RH; Nyhoff LE; Steinberg HE; Sullivan AM; Kendall PL
    J Immunol; 2015 Jul; 195(1):61-70. PubMed ID: 26034172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt.
    Craxton A; Jiang A; Kurosaki T; Clark EA
    J Biol Chem; 1999 Oct; 274(43):30644-50. PubMed ID: 10521450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCR engagement induces Fas resistance in primary B cells in the absence of functional Bruton's tyrosine kinase.
    Tumang JR; Negm RS; Solt LA; Schneider TJ; Colarusso TP; Hastings WD; Woodland RT; Rothstein TL
    J Immunol; 2002 Mar; 168(6):2712-9. PubMed ID: 11884437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel roles for Lyn in B cell migration and lipopolysaccharide responsiveness revealed using anti-double-stranded DNA Ig transgenic mice.
    Seo S; Buckler J; Erikson J
    J Immunol; 2001 Mar; 166(6):3710-6. PubMed ID: 11238611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B.
    Mizuno T; Rothstein TL
    J Immunol; 2003 Mar; 170(6):2806-10. PubMed ID: 12626529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Interaction between Lyn, Ets1, and Btk in the Control of Antibody Levels.
    Mayeux J; Skaug B; Luo W; Russell LM; John S; Saelee P; Abbasi H; Li QZ; Garrett-Sinha LA; Satterthwaite AB
    J Immunol; 2015 Sep; 195(5):1955-63. PubMed ID: 26209625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activation and subsequent regulatory roles of Lyn and CD19 after B cell receptor ligation are independent.
    Xu Y; Beavitt SJ; Harder KW; Hibbs ML; Tarlinton DM
    J Immunol; 2002 Dec; 169(12):6910-8. PubMed ID: 12471124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity.
    Middendorp S; Dingjan GM; Maas A; Dahlenborg K; Hendriks RW
    J Immunol; 2003 Dec; 171(11):5988-96. PubMed ID: 14634110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation.
    Kawakami Y; Kitaura J; Satterthwaite AB; Kato RM; Asai K; Hartman SE; Maeda-Yamamoto M; Lowell CA; Rawlings DJ; Witte ON; Kawakami T
    J Immunol; 2000 Aug; 165(3):1210-9. PubMed ID: 10903718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction.
    Fujimoto M; Poe JC; Satterthwaite AB; Wahl MI; Witte ON; Tedder TF
    J Immunol; 2002 Jun; 168(11):5465-76. PubMed ID: 12023340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice.
    Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Lowell CA; Tedder TF
    J Immunol; 2001 Sep; 167(5):2469-78. PubMed ID: 11509585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase.
    Khan WN
    Immunol Res; 2001; 23(2-3):147-56. PubMed ID: 11444380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transphosphorylation of Bruton's tyrosine kinase on tyrosine 551 is critical for B cell antigen receptor function.
    Kurosaki T; Kurosaki M
    J Biol Chem; 1997 Jun; 272(25):15595-8. PubMed ID: 9188445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of mature peripheral B cell populations in mice with concomitant defects in B cell receptor and BAFF-R signaling.
    Hoek KL; Carlesso G; Clark ES; Khan WN
    J Immunol; 2009 Nov; 183(9):5630-43. PubMed ID: 19843948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
    Buhl AM; Cambier JC
    J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced diabetes in btk-deficient nonobese diabetic mice and restoration of diabetes with provision of an anti-insulin IgH chain transgene.
    Kendall PL; Moore DJ; Hulbert C; Hoek KL; Khan WN; Thomas JW
    J Immunol; 2009 Nov; 183(10):6403-12. PubMed ID: 19841184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.